Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alemtuzumab induction in pediatric intestinal transplantation
NCT01208337Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Apr 2007
- Primary completion
- Nov 2014
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of alemtuzumab in graft rejection, sponsored by University of Pittsburgh. Started Apr 2007; status: completed.
02
Drugs
alemtuzumab
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT01208337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01208337.